PBAC

Also known as: Pharmaceutical Benefits Advisory Committee

The Australian committee that decides which medicines are listed on the publicly-funded PBS.

Definition

The Pharmaceutical Benefits Advisory Committee (PBAC) is an independent statutory body that advises the Australian Minister for Health on which medicines should be subsidised under the Pharmaceutical Benefits Scheme (PBS). Decisions are based on comparative effectiveness and cost-effectiveness (ICER thresholds typically AUD 45–75k/QALY).

See also

• TGA — Australia's medicines regulator.
• ICER (cost) — The cost-per-extra-QALY a treatment delivers compared to the standard of care.
• QALY — A measure combining length and quality of life used in cost-effectiveness analysis.

Other commercial terms

• Biosimilar
• Generic drug
• QALY
• NICE TA
• ICER (cost)
• WAC